You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 64 Issue 1

July 2007

Volume 64, Issue 1

Pages 1–118

  1. Editors' view

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content
  2. Pharmacokinetics & pharmacodynamics

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content
      Population pharmacokinetic and pharmacodynamic models of remifentanil in healthy volunteers using artificial neural network analysis (pages 3–13)

      S. H. Kang, M. R. Poynton, K. M. Kim, H. Lee, D. H. Kim, S. H. Lee, K. S. Bae, O. Linares, S. E. Kern and G. J. Noh

      Version of Record online: 23 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02845.x

      • image
      • image
      • image
      • image
      • image
    2. You have free access to this content
      The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies –CYP2C9 and warfarin as an example (pages 14–26)

      Gemma L. Dickinson, Martin S. Lennard, Geoffrey T. Tucker and Amin Rostami-Hodjegan

      Version of Record online: 12 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02850.x

      • image
      • image
      • image
      • image
      • image
      • image
  3. Pharmacokinetics

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content
      A population pharmacokinetic approach to ceftazidime use in burn patients: influence of glomerular filtration, gender and mechanical ventilation (pages 27–35)

      Jean Marie Conil, Bernard Georges, Michel Lavit, Jacky Laguerre, Kamram Samii, Georges Houin and Sylvie Saivin

      Version of Record online: 23 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02857.x

      • image
      • image
      • image
    2. You have free access to this content
      Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease (pages 36–48)

      Thorsten Lehr, Alexander Staab, Christiane Tillmann, Dirk Trommeshauser, Andreas Raschig, Hans Guenter Schaefer and Charlotte Kloft

      Version of Record online: 23 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02855.x

      • image
      • image
      • image
      • image
    3. You have free access to this content
      Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia (pages 49–56)

      Yi-lang Tang, Peixian Mao, Feng-Min Li, Wenbiao Li, Qi Chen, Feng Jiang, Zhuo-ji Cai and Philip B. Mitchell

      Version of Record online: 12 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02852.x

      • image
  4. Pharmacogenetics

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content
      Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or β-blockers and the risk of atherosclerosis (pages 57–66)

      H. Schelleman, O. H. Klungel, J. C. M. Witteman, A. Hofman, C. M. Van Duijn, A. De Boer and B. H. CH. Stricker

      Version of Record online: 12 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02848.x

      • image
      • image
      • image
    2. You have free access to this content
      Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects (pages 67–74)

      Yifan Zhang, Dayong Si, Xiaoyan Chen, Nan Lin, Yingjie Guo, Hui Zhou and Dafang Zhong

      Version of Record online: 12 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02846.x

      • image
      • image
      • image
  5. Drug safety

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content
      Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain (pages 75–82)

      Thomas Forst, Terry Smith, Klemens Schütte, Paul Marcus, Andreas Pfützner and for the CNS 5161 Study Group

      Version of Record online: 28 MAR 2007 | DOI: 10.1111/j.1365-2125.2007.02880.x

      • image
      • image
      • image
  6. Therapeutics

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content
    2. You have free access to this content
      Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey (pages 90–95)

      Derek Stewart, Abdul Rouf, Ailsa Snaith, Kathleen Elliott, Peter J. Helms and James S. McLay

      Version of Record online: 23 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02865.x

  7. Short reports

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content
      No association between CYP2D6 polymorphisms and personality trait in Japanese (pages 96–99)

      Kumiko Iwashima, Norio Yasui-Furukori, Ayako Kaneda, Manabu Saito, Taku Nakagami, Yasushi Sato and Sunao Kaneko

      Version of Record online: 23 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02858.x

    2. You have free access to this content
      Trends over 5 years in cardiovascular medicine use in Australian veterans with diabetes (pages 100–104)

      Elizabeth E. Roughead, Nicole Pratt and Andrew L. Gilbert

      Version of Record online: 12 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02853.x

      • image
      • image
    3. You have free access to this content
      Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis (pages 105–109)

      V. Jullien, A. Raïs, S. Urien, J. Dimet, C. Delaugerre, M. Bouillon-Pichault, E. Rey, G. Pons, S. Blanche and J. M. Tréluyer

      Version of Record online: 26 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02854.x

      • image
  8. Letters to the editors

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content
      Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation (pages 110–112)

      Raul Moreno, Cristina Fernandez, Angel Sanchez-Recalde, Luis Calvo, Guillermo Galeote, Rosa Sanchez-Aquino and Jose-Luis Lopez-Sendon

      Version of Record online: 22 DEC 2006 | DOI: 10.1111/j.1365-2125.2006.02840.x

      • image
    2. You have free access to this content
      Glimepiride-induced vasculitis: a case report (pages 113–114)

      Chaker Ben Salem, Houssem Hmouda and Kamel Bouraoui

      Version of Record online: 23 FEB 2007 | DOI: 10.1111/j.1365-2125.2007.02863.x

      • image
  9. Book review

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content
      Oxford Handbook of Nurse Prescribing (page 115)

      Helen Leathard

      Version of Record online: 22 MAR 2007 | DOI: 10.1111/j.1365-2125.2007.02879.x

  10. Obituary

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content
      John Trounce (pages 116–117)

      Roy G. Spector

      Version of Record online: 15 JUN 2007 | DOI: 10.1111/j.1365-2125.2007.02978.x

  11. Erratum

    1. Top of page
    2. Editors' view
    3. Pharmacokinetics & pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacogenetics
    6. Drug safety
    7. Therapeutics
    8. Short reports
    9. Letters to the editors
    10. Book review
    11. Obituary
    12. Erratum
    1. You have free access to this content

SEARCH

SEARCH BY CITATION